Peter Greenleaf

Insider Reports History

Entity
Individual
Location
One Medimmune Way, Gaithersburg, MD
Signature
/s/ Peter S. Greenleaf
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter Greenleaf:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aurinia Pharmaceuticals Inc. Chief Executive Officer, Director Common Stock 1.52M $8.52M $5.60 Mar 6, 2024 Direct
ANTARES PHARMA, INC. Director Common Stock 0 $5.60 May 24, 2022 Direct
ANTARES PHARMA, INC. Director Stock Option (right to buy) 0 May 24, 2022 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Common Stock 0 $1.80 Mar 22, 2022 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Restricted Stock Units 0 Mar 22, 2022 Direct
BIODELIVERY SCIENCES INTERNATIONAL INC Director Stock Options (right to buy) 0 $2.93 Mar 22, 2022 Direct

Insider Reports Filed by Peter Greenleaf

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AUPH Aurinia Pharmaceuticals Inc. Mar 6, 2024 1 -$711K 4 Mar 7, 2024 Chief Executive Officer, Director
AUPH Aurinia Pharmaceuticals Inc. Feb 20, 2024 1 $0 4 Feb 22, 2024 Chief Executive Officer, Director
AUPH Aurinia Pharmaceuticals Inc. Mar 2, 2023 1 -$290K 4/A Feb 22, 2024 Chief Executive Officer, Director
AUPH Aurinia Pharmaceuticals Inc. Mar 2, 2023 2 -$293K 4 Mar 6, 2023 Chief Executive Officer, Director
ATRS ANTARES PHARMA, INC. May 24, 2022 6 -$446K 4 May 26, 2022 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Mar 22, 2022 4 $0 4 Mar 22, 2022 Director
AUPH Aurinia Pharmaceuticals Inc. Mar 2, 2022 4 -$109K 4 Mar 4, 2022 Chief Executive Officer, Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Jan 27, 2022 4 $419K 4 Jan 31, 2022 Director
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC Aug 6, 2021 2 $0 4 Aug 10, 2021 Director
ATRS ANTARES PHARMA, INC. Jun 10, 2021 2 $112K 4 Jun 14, 2021 Director
AUPH Aurinia Pharmaceuticals Inc. May 11, 2021 2 $54.9K 4 May 12, 2021 Chief Executive Officer, Director